ORIGINAL ARTICLE |
|
Year : 2015 | Volume
: 42
| Issue : 2 | Page : 49-54 |
|
Effects of interleukin-10 gene polymorphism on clinical diversity and activity of systemic lupus erythematosus
Ahmad A Emerah MD 1, Kamal F Mohamed2, Nisreen E Elbadawy2, Mai H Rashad2
1 Department of Rheumatology and Rehabilitation, Faculty of Medicine, Zagazig University, Zagazig, Egypt 2 Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Correspondence Address:
Dr. Ahmad A Emerah Zagaig University Hospitals, Rheumatology and Rehablitation Department, Sharkia Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/1110-161X.157855
|
|
Aim
This study was carried out to determine the effects of interleukin (IL)-10 gene polymorphism 1082A/G on clinical diversity and activity of systemic lupus erythematosus (SLE), as it was shown to be associated with E26 transcription factor binding site, and to assess IL-10 concentration in SLE patients.
Patients and methods
Blood was drawn from 54 SLE patients and 27 healthy controls for DNA extraction. The single nucleotide polymorphism was identified using the PCR-restriction fragment length polymorphism, and serum sample was collected to assay IL-10 concentration.
Results
There was an increase in IL-10 concentration in SLE total patients (mean 49.5 pg/ml). Mutant allele A (76.9%) was found more frequently in SLE patients compared with allele G (23.1%). Genotype AA (66.7%) was found more frequently, followed by AG (20.4%) and GG (12.9%).
Conclusion
IL-10 concentration was elevated in SLE patients and was shown to be associated with disease activity. IL-10 gene polymorphism is not a strong indicator to show susceptibility of the disease. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|